FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 204 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe EMA Recommends Extension of Therapeutic Indications for Ponatinib MOST POPULAR Breast Cancer Survivor’s Family Designs a Holiday Light Show in Her... December 15, 2020 Expression of AR-regulated Genes in CTCs Is Prognostic for Survival and... July 7, 2021 Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis,... February 10, 2026 Our COVID-19 Response: How GreaterGood Is Making An Impact During The... April 23, 2020 Load more HOT NEWS Virtual Reality Found to Benefit Cancer Patients’ Mental Health When He Said His Mother-In-Law Was Going To Live In The... Neoadjuvant Docetaxel, Oxaliplatin, and S-1, as Part of Perioperative Chemotherapy, Prolongs... Women in Science: Celebrating with our Women of Influence initiative
